Pharmacists Must Create Patient Demand for Medication Therapy Management
This article was originally published in The Pink Sheet Daily
Executive Summary
Patients must be shown the value of medication therapy management, Walgreens exec Daniel Luce says. CMS warns pharmacists to be conservative in predicting compensation available from the Medicare drug benefit’s medication therapy management component.
You may also be interested in...
Medicare Drug Management Programs Formalize Pharmacist Role As Provider
Medication therapy management programs created by the Medicare drug benefit are “the single greatest opportunity for pharmacy in over 30 years,” Kerr Drugs exec tells NACDS conference. Potential fees from such programs are a significant compensation opportunity for pharmacies, Longs Drugs VP says.
Purdue Signs On To Market Labopharm's Once-Daily Tramadol
Labopharm will receive up to $170 mil. under the licensing deal, including $20 mil. up front and $40 mil. upon NDA approval.
Merck KGaA Boosts U.S. Generic Market Presence With Genpharm Expansion
Genpharm opens office in New York headed by former Able CEO Robert Mauro.